Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 668.93% | 728.20% | 753.48% | 1,094.85% | -58.66% |
| Total Depreciation and Amortization | 39.71% | 4.25% | -2.22% | 0.17% | -21.60% |
| Total Amortization of Deferred Charges | 34.81% | 34.81% | 1,264.45% | 1,264.45% | 1,264.45% |
| Total Other Non-Cash Items | -3,974.80% | -803.78% | 1,291.94% | 1,059.66% | -101.47% |
| Change in Net Operating Assets | 85.80% | -2.67% | -229.63% | -282.90% | -165.79% |
| Cash from Operations | 654.13% | 834.27% | 1,220.12% | 1,665.98% | -162.18% |
| Capital Expenditure | -219.53% | -245.16% | -13.57% | 13.35% | 9.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.12% | 67.55% | 75.63% | -476.77% | -127.47% |
| Cash from Investing | 43.53% | 67.13% | 75.45% | -470.43% | -126.69% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -49.68% | -20.58% | 10.03% | 9.45% | 96.95% |
| Issuance of Common Stock | -99.34% | -99.43% | -99.62% | -99.59% | 134.20% |
| Repurchase of Common Stock | -15.73% | -15.73% | -15.73% | -644.43% | -745.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 99.96% | 98.95% | -125.22% |
| Cash from Financing | -106.32% | -104.83% | -105.02% | -107.10% | 136.98% |
| Foreign Exchange rate Adjustments | 5,421.11% | -972.41% | -1,295.85% | -6,058.00% | -112.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,322.93% | 4,964.99% | 43,573.97% | -98.86% | -59.00% |